Trial intelligence / Profile preview

Phase 3 cannabis extract for chronic non-specific low back pain

2020-000107-36Phase 3Completed

Sponsor
Vertanical
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of standardized cannabis sativa thc extract in Low back pain (LBP), sponsored by Vertanical. Primary endpoint: Primary endpoint (Phase A). Started Dec 2020; status: completed.

02

Drugs

standardized cannabis sativa thc extract
03

Conditions

Low back pain (LBP)

Beyond the preview

Go deeper on 2020-000107-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-000107-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call